Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.1K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

73
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
73
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

1.2K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.2K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

10.7K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
10.7K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

468
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
468
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

626
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
626

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Technical note: A flexible framework for precision reduction of WRF inputs and outputs to balance storage efficiency and scientific fidelity.

Atmospheric chemistry and physics·2026
Same author

Efficacy and safety comparisons of PD-1 versus PD-L1 inhibitors in patients with solid cancer: a systematic review and meta-analysis.

Journal of the National Cancer Center·2026
Same author

Brown Adipocyte Sheets Alleviate Myocardial Ischemia-Reperfusion Injury Through NRG4-ErbB4-Dependent Ferroptosis Inhibition.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Pilot tests of continuous gas extraction with improved L-shaped wells from mining and goaf areas.

Scientific reports·2026
Same author

Enzyme-responsive 612-AYR nanoparticles for targeted inhibition of B4GALT3-mediated ITGB1 glycosylation in hepatocellular carcinoma.

British journal of pharmacology·2026
Same author

Effects of Grape Seed Proanthocyanidins with Different Polymerization Degrees on the Phenolic Compounds and Sensory Quality of Cabernet Sauvignon Wine During Bottle Aging.

Foods (Basel, Switzerland)·2026
Same journal

Revealing the correlation between chemical composition and pharmacological effects of medicinal plants in the Ilex L. genus.

Fitoterapia·2026
Same journal

Polycyclic phenolic compounds from the Antarctic moss Polytrichum strictum and their potential in treating cancer and obesity.

Fitoterapia·2026
Same journal

Serratene triterpenoids from Phlegmariurus cruentus with cytotoxic activity and their proapoptotic effect.

Fitoterapia·2026
Same journal

Strategies for quantitative analysis and preparation of hepatoprotective rosmarinic acid of Lycopus lucidus aerial parts.

Fitoterapia·2026
Same journal

Hispidin-enriched Sanhuangporus sanghuang ethanolic extract: A novel GLP-1 inducer with non-mutagenic properties.

Fitoterapia·2026
Same journal

Retraction notice to 'Chemical identification of the Viola phillipina extracts and their anti-acne activity: A comparison with isotretinoin and salicylic acid' [Fitoterapia 191 (2026) 107238].

Fitoterapia·2026
See all related articles

Related Experiment Video

Updated: Dec 2, 2025

Optimization of the Epimedii Folium Mutton-Oil Processing Technology and Testing Its Effect on Zebrafish Embryonic Development
06:00

Optimization of the Epimedii Folium Mutton-Oil Processing Technology and Testing Its Effect on Zebrafish Embryonic Development

Published on: March 17, 2023

714

Multifunctional epiberberine mediates multi-therapeutic effects.

Linqiu Liu1, Junjun Li1, Yang He1

  • 1College of Medical Technology, State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

Fitoterapia
|November 5, 2020
PubMed
Summary
This summary is machine-generated.

Epiberberine, a natural compound from Coptis chinensis, shows promise for treating chronic diseases. This alkaloid exhibits multi-target therapeutic effects with low toxicity, including anti-cancer and anti-diabetic properties.

Keywords:
Coptis chinensisEpiberberineMetabolism pathwayPharmacological actions

More Related Videos

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

1.6K

Related Experiment Videos

Last Updated: Dec 2, 2025

Optimization of the Epimedii Folium Mutton-Oil Processing Technology and Testing Its Effect on Zebrafish Embryonic Development
06:00

Optimization of the Epimedii Folium Mutton-Oil Processing Technology and Testing Its Effect on Zebrafish Embryonic Development

Published on: March 17, 2023

714
Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

1.6K

Area of Science:

  • Pharmacology
  • Natural Products Chemistry
  • Medicinal Chemistry

Background:

  • Epiberberine is a protoberberine alkaloid derived from Coptis chinensis Franch.
  • It has demonstrated potential in treating various chronic diseases.

Purpose of the Study:

  • To summarize recent research on the therapeutic effects of epiberberine.
  • To highlight its multi-target activities and potential applications.

Main Methods:

  • Literature review of studies published in the last two decades.
  • Searches conducted on Web of Science, ScienceDirect, PubMed, and Springer.
  • Keywords included 'epiberberine', 'Coptis', and specific therapeutic targets.

Main Results:

  • Epiberberine acts as a multi-target small molecule with low toxicity.
  • Demonstrated activities include anti-adipogenesis (Akt/ERK pathways), anti-dyslipidemia (cholesterol synthesis inhibition), and anti-cancer (p53/Bax apoptosis pathway).
  • Also shows anti-bacterial effects and potential benefits for diabetes and Alzheimer's disease.

Conclusions:

  • Epiberberine exhibits diverse therapeutic potential for various diseases.
  • Further investigation into clinical applications and molecular mechanisms, especially in diabetes and dementia, is warranted.